Soluble Human Suppression of Tumorigenicity 2 Is Associated with Endoscopic Activity in Patients with Moderate-To-Severe Ulcerative Colitis Treated with Golimumab
AuthID
P-00R-0YF
P-00R-0YF
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service